DRL stocks: Buy Dr. Reddy’s Laboratories, target price Rs 5134: ICICI Securities

has buy call on Dr. Reddy’s Laboratories with a target price of Rs 5134. The current market price of Dr. Reddy’s Laboratories is Rs 4544.45. Time period given by analyst is one year when Dr. Reddy’s Laboratories Ltd. price can reach defined target.

Dr. Reddy’s Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 74243.28 Crore) operating in Pharmaceuticals sector.

Dr. Reddy’s Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Licence Fees, Other Operating Revenue, Spent Chemicals, Service Income and Scrap for the year ending 31-Mar-2022.


For the quarter ended 30-09-2022, the company reported a Consolidated Total Income of Rs 6372.60 Crore, up 4.70 % from last quarter Total Income of Rs 6086.80 Crore and up 6.34 % from last year same quarter Total Income of Rs 5992.40 Crore. Company reported net profit after tax of Rs 1100.20 Crore in latest quarter.

Promoter/FII Holdings
Promoters held 26.71 per cent stake in the company as of 30-Sep-2022, while FIIs owned 25.87 per cent, DIIs 24.6 per cent.

(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button